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Correspondence
Reply to Worth et al
TO THE EDITOR—We thank Worth and
colleagues [1] for reflecting on some im-
portant points related to our recent study
where we reported a 63% reduction in
hospital-onset (HO) Staphylococcus au-
reus bacteremia (SAB) in Australia [2].
We agree that theHO-SABdefinition used
in our study is not the national definition
currently used for healthcare-associated
(HCA) SAB surveillance in Australian
hospitals. We commented on this in the
discussion. Authors of our study have
previously made similar comments to
those made by Worth and colleagues
[3–8]. For the purposes of benchmarking
Australia internationally, we believe a
HO-SAB definition is a robust and accu-
rate approach to identify any real reduc-
tion in SAB—the aim of the paper.
Capturing all HCA-SAB cases requires
much more additional work by infection
control professionals and infectious dis-
eases physicians at a local level. In addition,
collecting such additional surveillance re-
quires validation [9, 10], potentially lack-
ing in parts of Australia. However, there
are 2 important reasons why we used only
a HO-SAB definition in our study. First,
we wanted to report data over a long time
frame, 12 years of data. The HCA-SAB
definition was not agreed upon by Health
Ministers until 2008 in Australia, mean-
ing previous longitudinal prospective
data were not collected consistently. Ret-
rospective analysis would have been very
difficult and likely subject to bias. Second,
the HO-SAB definition allows for inter-
national comparisons, whereas the HCA-
SAB definition does not. Without using
a HO-SAB definition, we would not have
been able to undertake the compari-
sons outlined in our discussion. We
fully support the use of HCA-SAB sur-
veillance definition and hope that many
other countries move to such a definition
for the reasons described by Worth and
colleagues. We believe that when data
are presented, HO-SAB should be pre-
sented as a subset of the total HCA-SAB
numbers where possible. Comparisons
can then be made with studies that have
not used the more inclusive definition.
The conclusions in our study are consis-
tent with the definitional approach we
used. We never stated or implied that
we tried to measure and report all cases
of HCA-SAB.
We acknowledge the point made by
Worth and colleagues regarding data
analysis and model adjustment for het-
erogeneity and multistate frailty. We are
not convinced that this extra complexity
in analysis is needed to demonstrate the
points made. Regardless, under the agree-
ments with those providing data for our
study, only aggregated hospital data
were to be analyzed and published, so
the proposed analysis was not possible.
What our data showed was a major and
significant reduction in incidence of
HO-SAB over a 12-year period caused
by both methicillin-resistant and methi-
cillin-sensitive S. aureus in Australian
hospitals since 2002. This reduction coin-
cided with a range of infection prevention
and control activities implemented dur-
ing this time [2]. It suggests that national
and local efforts to reduce the burden
have been very successful. As we com-
mented, there are many potential reasons
for the reductions in HO-SAB observed
in our study, and Worth and colleagues
are correct in acknowledging the impor-
tant role that surveillance and multiple
interventions play [11, 12].
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